期刊文献+

维持性透析患儿钙磷代谢和甲状旁腺功能的变化 被引量:2

Changes of calcium-phosphorus metabolism and parathyroid function in maintenance hemodialysis children
下载PDF
导出
摘要 目的探讨维持性血液透析(MHD)患儿钙磷代谢和甲状旁腺功能的变化。方法观察首都医科大学附属北京儿童医院肾内科血液净化中心行MHD的19例终末期肾脏病患儿,记录透析前及透析3月后钙、磷、碱性磷酸酶及全段甲状旁腺激素(iPTH)水平,根据改善全球肾脏病预后国际组织指南标准进行比较,分析透析患儿钙磷代谢的达标率。结果 19例MHD患儿透析前高磷血症16例(84.21%);低钙血症17例(89.47%);碱性磷酸酶增高11例(57.69%);血iPTH高于600pg/ml的13例(66.42%)。透析3月后血磷(1.83±0.76)mmol/L、血钙(2.27±0.26)mmol/L、碱性磷酸酶(401.63±315.61)U/L及iPTH(675.97±581.66)ng/L,达标率分别为10例(52.63%)、15例(78.95%)、5例(26.32%)及10例(52.63%)。透析3月后与透析前比较,碱性磷酸酶无统计学意义(t=-1.497,P>0.05),血磷、血iPTH水平明显下降(分别为t=3.477,P<0.01;t=2.397,P<0.05),血钙水平明显升高(t=-7.392,P<0.01)。结论 MHD患儿普遍存在钙磷代谢紊乱和甲状旁腺功能异常,应当予以重视。通过本组研究发现,应用MHD联合血液透析滤过方案可以改善钙磷代谢紊乱。儿童碱性磷酸酶是否可以作为钙磷代谢紊乱的观察指标尚需进一步研究。 Objective To investigate the changes of serum calcium-phosphorus metabolism and parathyroid function in maintenance hemodialysis (MHD) children.Methods A total of 19 MHD children treated in our blood purification center were enrolled in this study.Serum calcium,phosphate and intact parathyroid hormone (iPTH) were measured before and after MHD for 3 months.Results Before MHD,hyperphosphatemia was found in 16 patients (84.21%),hypocalcemia in 17 patients (89.47%),elevated alkaline phosphatase in 11 patients (57.69%),and iPTH level >600 pg/ml in 13 patients (66.42%).After MHD for 3 months,the mean level of serum phosphorus,calcium,alkaline phosphatase,and iPTH was 1.83±0.76 mmol/L,2.27±0.26 mmol/ L,401.63±315.61 U/L,and 675.97±581.66 ng/L,respectively,approaching the target level of serum phosphorus,calcium,alkaline phosphatase,and iPTH in 10 patients (52.63%),15 patients (78.95%),5 patients (26.32%),and 10 patients (52.63%),respectively.While serum alkaline phosphatase changed insignificantly (t =-1.497,P>0.05),serum phosphorus and iPTH decreased (t =3.477,P<0.01,and t =2.397,P<0.05,respectively) and serum calcium increased (t =-7.392,P<0.01) after MHD for 3 months as compared to those before MHD.Conclusions MHD children are frequently complicated with calcium-phosphorus metabolic derangements and secondary hyperparathyroidism,which should be carefully monitored.MHD combined with hemodiafiltration may be more effective to improve these derangements.Whether alkaline phosphatase can be used as the indicator for calcium-phosphorus metabolic changes in children needs to be further studied.
出处 《中国血液净化》 2014年第9期636-638,共3页 Chinese Journal of Blood Purification
关键词 维持性透析 钙代谢障碍 磷代谢障碍 甲状旁腺素 Maintenance hemodialysis Calcium metabolism disorder Phosphorus metabolism disorder Parathyroid hormone
  • 相关文献

参考文献11

  • 1Uhlig K1, Berns JS, Kestenbaum B, et al. KDOQI US com mentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD- Mineral and Bone Disorder (CKD-MBD) [J]. Am J Kidney Dis, 2010, 55:773-99.
  • 2邵洁.儿童维生素D、钙营养与骨健康 儿童维生素D、钙营养与营养性维生素D缺乏性佝偻病判定与评价现状[J].中国实用儿科杂志,2012,27(3):161-165. 被引量:54
  • 3王平,黄文彦.儿童慢性肾脏病钙磷代谢问题[J].中国实用儿科杂志,2011,26(6):411-414. 被引量:3
  • 4胡亚美 江载芳 诸福棠.实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1900.
  • 5Chavers BM, Solid CA, Sinaiko A, Diagnosis of cardiac disease in pediatric end- stage renal disease[J]. Nephrol Dial Transplant, 2011, 26:1640-1645.
  • 6Fraser WD. Hyperparathyroidism[j].Lancet, 2009, 374: 145-158.
  • 7Smith LB, Fadrowski JJ, Howe CJ. Secondary Hyperpara- thyroidism and Anemia in Children Treated by Hemodialy sis[J]. Am J Kidney Dis, 2010, 55:326-334.
  • 8Youssef DM, Elshal AS, Abo Elazem AA. Assessment of im- mune status in relation to vitamin D levels in chil- dren on regular hemodialysis[J]. Saudi J Kidney Dis Transpl, 2012, 23:267-273.
  • 9李月红,王梅.北京市2007年慢性维持性血液透析患者钙磷代谢分析[J].中国血液净化,2010,9(2):112-115. 被引量:56
  • 10Abe M, Okada K, Soma M. Mineral Metabolic Abnormali- ties and Mortality in Dialysis Patients[J]. Nutrients, 2013, 5: 1002-1023.

二级参考文献59

  • 1张亚钦,李辉,吴秀娟.定量超声技术在评价儿童青少年骨骼发育中的价值[J].实用儿科临床杂志,2007,22(7):534-535. 被引量:34
  • 2Kimata N, Albert JM, Akiba T, et al. Association of mineral metabolism factors with all cause and cardiovascular mor tality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study[J].Hemodial Int, 2007, 11:340-348.
  • 3Wald R, Tentori F, Tighiouart H, et al. Impact of the Kidney Disease outcomes Quality Initiative(KDOQI)Clinical practice Guidelines for Bone Metabolism and Disease in a large dialysis network[J].Am I Kidney Dis, 2007,49:257 266.
  • 4Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].Am J Kidney Dis, 2008, 52:519- 530.
  • 5Mendelssohn DC, Pisoni RL, hrrington CJ, et al.A practice- related risk score (PRS): A DOPPS-derived aggregate qual ity index for haemodialysis facilities[J].Nephrol Dial Transplant, 2008,23:3227-3233.
  • 6王海燕,王梅主译.慢性肾脏病及透析的临床实践指南[M].北京人民卫生出版社,2003,89.
  • 7Block GA, Klassen PS, LazarusJM, et al. Mineralmetabolism, mortality, and morbidity in maintenance hemodialysis[J]. J Am Soc Nephrol,2004,15:2208 2218.
  • 8Chertow GM, Raggi P, Chasan Tabar S, et al. Determinants of progressive vascular calcification in hemodia]ysis patients [J]. Nephrol Dial Transplant, 2004,19:1489-1496.
  • 9~ang H, Curinga G, Giachelli CM. Elevated extracellular cal cium levels induce smooth muscle cell matrix mineraliza tion in vitro[J]. Kidney Int, 2004,66:2293-2299.
  • 10Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease : improving global outcomes (KDIGO) [J]. Kidney Int, 2006,69: 1945-1953.

共引文献682

同被引文献6

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部